Support for public provision of a private good with top-up and opt-out: A controlled laboratory experiment
MetadataShow full item record
This paper presents the results of a revealed-choice experiment testing the theoretical predictions of political economy models regarding public support for a publicly provided private good financed with proportional income taxes when individuals can purchase the good privately and either continue to consume public provision (‘top-up’) or forego public provision (‘opt-out’), but in each case continue to pay income taxes. Our laboratory results confirm behavior is consistent with the predicted majority-preferred tax rate under mixed financing with top-up, but we identify preferences for significantly higher rates of public provision than predicted under mixed financing with opt-out. Using non parametric regression analysis, we explore the relationship between individuals’ top-up and opt-out decisions and both their income levels and the implemented tax rates.
Showing items related by title, author, creator and subject.
Leidel, S.; McConigley, Ruth; Boldy, Duncan; Wilson, Sally; Girdler, Sonya (2015)Background: Opt-out HIV testing is a novel concept in Australia. In the opt-out approach, health care providers (HCPs) routinely test patients for HIV unless they explicitly decline or defer. Opt-out HIV testing is only ...
Leidel, S.; Leslie, G.; Boldy, Duncan; Davies, A.; Girdler, Sonya (2017)© 2017 La Trobe University. This study explored opt-out HIV testing in an Australian general practice. The aims were to: (1) determine the effect of the opt-out approach on the number of HIV tests performed; and (2) explore ...
The first 1000 patients on an internet-based colorectal neoplasia database across private and public medicine in australia: Development of a binational model for the colorectal surgical society of Australia and New ZealandMcMurrick, P.; Oliva, K.; Carne, P.; Reid, Christopher; Polglase, A.; Bell, S.; Farmer, K.; Ranchod, P. (2014)Background: Collection of multi-institutional data pertaining to the treatment of bowel cancer has been hindered by poor clinician compliance with data entry and the lack of incentive to participate. Objective: This study ...